Brown Michael Jon reported tax withholding involving 1,451 shares of DEXCOM INC at $79.41 for −$115k on Nov 8, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
EVP Chief Legal Compliance Off
EVP Chief Legal Compliance Off
Filed Nov 10, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$115,223.91Shares × reported price
Shares traded
1,451Common Stock
Price per share
$79.41Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
96,734Direct
Trade date
Nov 8, 2026Tax withholding
Filed
Nov 10, 2026, 4:35 PM ET2-day reporting delay
Accession
0001093557-26-000206Code F · Transaction 397179
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

DXCM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
DXCM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +5.2%1w ago +3%1d ago −0.6%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person. F2: Included in this number are 69,053 unvested restricted stock units, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 2,849 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027.